Related Experiment Video

Updated: Jan 13, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.3K

Prevention and Management of Heart Failure Associated with Type 2 Diabetics in Rural Australia

Allen G Ross1, Utpal K Mondal2, Shakeel Mahmood2

  • 1College of Medicine, Ajman University, Ajman 346, United Arab Emirates.

Journal of Clinical Medicine
|January 10, 2026
PubMed

Insights

Sodium-glucose cotransporter 2 (SGLT2) inhibitors significantly reduce heart failure (HF) hospitalizations in HF with preserved ejection fraction (HFpEF) patients. Improving rural healthcare access and workforce is crucial for reducing preventable hospitalizations from HF and type 2 diabetes in Australia.

Area of Science:

  • Cardiology
  • Endocrinology
  • Rural Health

Background:

  • Heart failure with preserved ejection fraction (HFpEF) has limited treatment options.
  • Recent trials show sodium-glucose cotransporter 2 (SGLT2) inhibitors significantly reduce HF hospitalizations in HFpEF.
  • SGLT2 inhibitors are now supported by Australian and international guidelines for HFpEF.

Purpose of the Study:

  • To review the effectiveness of SGLT2 inhibitors for HFpEF.
  • To examine heart failure (HF) and diabetes hospitalization rates in Australia, particularly in rural areas.
  • To identify strategies for reducing preventable hospitalizations and mortality in rural Australia.

Main Methods:

  • Narrative review utilizing a structured multi-database search (MEDLINE, Embase, CINAHL, Scopus).
  • Inclusion of key Australian health data sources (AIHW, ABS, Department of Health and Aged Care).
  • No restrictions on geographic location or publication year.

Main Results:

  • Approximately 179,000 HF hospitalizations in Australia (2020-2021), with higher rates in remote areas.
  • Diabetes prevalence has nearly tripled since 2000, with significantly higher hospitalization rates in remote areas.
  • Rural residents are 2.5 times more likely to be hospitalized for diabetes compared to major city residents.

Conclusions:

  • Reducing preventable hospitalizations and premature mortality from heart failure and type 2 diabetes in rural Australia requires a stronger rural healthcare workforce.
  • Improved access to essential medicines and telehealth is vital.
  • Equity-focused evaluation is necessary to address disparities in rural healthcare outcomes.

Keywords:
heart failuremanagementpreventionrural Australiatreatmenttype 2 diabetes

More Related Videos

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

579
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.4K

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
208
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
856
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
408
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
909
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
277